Paradoxical psoriasiform reactions to antitumour necrosis factor-α drugs in hidradenitis suppurativa

Br J Dermatol. 2018 Jan;178(1):281-283. doi: 10.1111/bjd.15616. Epub 2017 Nov 10.

Authors

L Dequidt¹, O Cogrel¹, S Guillet¹, B Milpied¹, A S Darrigade¹, M Beylot-Barry¹, A Pham-Ledard¹

Affiliation

¹ Dermatology Department, University Hospital of Bordeaux, Bordeaux, France.

PMID: 28444990
DOI: 10.1111/bjd.15616

No abstract available

Publication types

Letter

MeSH terms

Adalimumab / administration & dosage*
Adalimumab / adverse effects
Adult
Dermatologic Agents / adverse effects*
Female
Hidradenitis Suppurativa / drug therapy*
Humans
Infliximab / adverse effects*
Male
Psoriasis / chemically induced*
Recurrence
Retrospective Studies
Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

Dermatologic Agents
Tumor Necrosis Factor-alpha
Infliximab
Adalimumab